New treatments for myasthenia: a focus on antisense oligonucleotides.

about

Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.

P2860

Q36454649-CCED5E9F-9B6F-45A8-9B0E-5932BC2BEA3B

P2860

New treatments for myasthenia: a focus on antisense oligonucleotides.

Item

http://www.wikidata.org/entity/Q38076108

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

New treatments for myasthenia: a focus on antisense oligonucleotides.

@en

type

Item

label

New treatments for myasthenia: a focus on antisense oligonucleotides.

@en

prefLabel

New treatments for myasthenia: a focus on antisense oligonucleotides.

@en

P1476

New treatments for myasthenia: a focus on antisense oligonucleotides.

@en

P2093

Michela Bisciglia

http://www.w3.org/2001/XMLSchema#string

Sara Martignago

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular architecture of the neuromuscular junction

Acetylcholinesterase--new roles for an old actor

Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression

Virtues and woes of AChE alternative splicing in stress-related neuropathologies

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

Tracking cholinergic pathways from psychological and chemical stressors to variable neurodeterioration paradigms.

Acute stress facilitates long-lasting changes in cholinergic gene expression.

The origin of the molecular diversity and functional anchoring of cholinesterases.

P304

13-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/DDDT.S25716

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Corrado Angelini

P577

2013-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23341732

http://www.w3.org/2001/XMLSchema#string

P921

nucleotides

myasthenia gravis

P932

3546757

http://www.w3.org/2001/XMLSchema#string

New treatments for myasthenia: a focus on antisense oligonucleotides.

about

P2860

P2860

New treatments for myasthenia: a focus on antisense oligonucleotides.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932